BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

332 related articles for article (PubMed ID: 22781788)

  • 1. Hot flushes and night sweats differ in associations with cardiovascular markers in healthy early postmenopausal women.
    Hitchcock CL; Elliott TG; Norman EG; Stajic V; Teede H; Prior JC
    Menopause; 2012 Nov; 19(11):1208-14. PubMed ID: 22781788
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oral micronized progesterone for vasomotor symptoms--a placebo-controlled randomized trial in healthy postmenopausal women.
    Hitchcock CL; Prior JC
    Menopause; 2012 Aug; 19(8):886-93. PubMed ID: 22453200
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hot flushes and night sweats are associated with coronary heart disease risk in midlife: a longitudinal study.
    Herber-Gast G; Brown WJ; Mishra GD
    BJOG; 2015 Oct; 122(11):1560-7. PubMed ID: 25377022
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Menopausal symptoms and risk factors for cardiovascular disease in postmenopause.
    Cagnacci A; Cannoletta M; Palma F; Zanin R; Xholli A; Volpe A
    Climacteric; 2012 Apr; 15(2):157-62. PubMed ID: 22141325
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vasomotor symptoms and cardiovascular disease risk.
    Pines A
    Climacteric; 2011 Oct; 14(5):535-6. PubMed ID: 21848496
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factors associated with resilience or vulnerability to hot flushes and night sweats during the menopausal transition.
    Duffy OK; Iversen L; Aucott L; Hannaford PC
    Menopause; 2013 Apr; 20(4):383-92. PubMed ID: 23250082
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vasomotor symptoms and mortality: the Rancho Bernardo Study.
    Svartberg J; von Mühlen D; Kritz-Silverstein D; Barrett-Connor E
    Menopause; 2009; 16(5):888-91. PubMed ID: 19421076
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neck circumference: a useful screening tool of cardiovascular risk in children.
    Androutsos O; Grammatikaki E; Moschonis G; Roma-Giannikou E; Chrousos GP; Manios Y; Kanaka-Gantenbein C
    Pediatr Obes; 2012 Jun; 7(3):187-95. PubMed ID: 22505226
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Menopausal hot flushes and night sweats: where are we now?
    Archer DF; Sturdee DW; Baber R; de Villiers TJ; Pines A; Freedman RR; Gompel A; Hickey M; Hunter MS; Lobo RA; Lumsden MA; MacLennan AH; Maki P; Palacios S; Shah D; Villaseca P; Warren M
    Climacteric; 2011 Oct; 14(5):515-28. PubMed ID: 21848495
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Progesterone for hot flush and night sweat treatment--effectiveness for severe vasomotor symptoms and lack of withdrawal rebound.
    Prior JC; Hitchcock CL
    Gynecol Endocrinol; 2012 Oct; 28 Suppl 2():7-11. PubMed ID: 22849758
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictors of hot flushes in postmenopausal women who receive raloxifene therapy.
    Aldrighi JM; Quail DC; Levy-Frebault J; Aguas F; Kosian K; Garrido L; Bosio-Le Goux B; Saráchaga M; Graebe A; Niño AJ; Nickelsen T
    Am J Obstet Gynecol; 2004 Dec; 191(6):1979-88. PubMed ID: 15592280
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of micronutrient supplementation on vasomotor symptoms in postmenopausal women.
    Andrikoula M; Baker D; Nesic J; Liao LM; Duka T; Prelevic GM
    Climacteric; 2011 Oct; 14(5):544-50. PubMed ID: 21413865
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vasomotor symptoms, estradiol levels and cardiovascular risk profile in women.
    Gast GC; Samsioe GN; Grobbee DE; Nilsson PM; van der Schouw YT
    Maturitas; 2010 Jul; 66(3):285-90. PubMed ID: 20400247
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Progesterone therapy, endothelial function and cardiovascular risk factors: a 3-month randomized, placebo-controlled trial in healthy early postmenopausal women.
    Prior JC; Elliott TG; Norman E; Stajic V; Hitchcock CL
    PLoS One; 2014; 9(1):e84698. PubMed ID: 24465425
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Medroxyprogesterone and conjugated oestrogen are equivalent for hot flushes: a 1-year randomized double-blind trial following premenopausal ovariectomy.
    Prior JC; Nielsen JD; Hitchcock CL; Williams LA; Vigna YM; Dean CB
    Clin Sci (Lond); 2007 May; 112(10):517-25. PubMed ID: 17419685
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hormone therapy and coronary heart disease risk by vasomotor menopausal symptoms.
    Gast GC; Pop VJ; Samsioe GN; Grobbee DE; Nilsson PM; Keyzer JJ; Wijnands-van Gent CJ; van der Schouw YT
    Maturitas; 2011 Dec; 70(4):373-8. PubMed ID: 21978631
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vasomotor symptoms and risk of cardiovascular disease in peri- and postmenopausal women: A systematic review and meta-analysis.
    Armeni A; Anagnostis P; Armeni E; Mili N; Goulis D; Lambrinoudaki I
    Maturitas; 2023 May; 171():13-20. PubMed ID: 36907116
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Understanding the pathophysiology of vasomotor symptoms (hot flushes and night sweats) that occur in perimenopause, menopause, and postmenopause life stages.
    Deecher DC; Dorries K
    Arch Womens Ment Health; 2007; 10(6):247-57. PubMed ID: 18074100
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sleep in midlife women: effects of menopause, vasomotor symptoms, and depressive symptoms.
    Lampio L; Polo-Kantola P; Polo O; Kauko T; Aittokallio J; Saaresranta T
    Menopause; 2014 Nov; 21(11):1217-24. PubMed ID: 24755900
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association between menopausal symptoms and metabolic syndrome in postmenopausal women.
    Lee SW; Jo HH; Kim MR; Kwon DJ; You YO; Kim JH
    Arch Gynecol Obstet; 2012 Feb; 285(2):541-8. PubMed ID: 21853251
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.